Dr. Arthur Kavanaugh

Arthur F. Kavanaugh, MDArthur Kavanaugh, MD,  is Professor of Medicine and Director of the Center for Innovative Therapy (CIT) at  UC San Diego. Dr. Kavanaugh  received his medical degree at Saint Louis University, School of Medicine, St. Louis, MO and completed his internal medicine residency and allergy/immunology fellowship at
Baylor College of Medicine, Houston, Texas followed by a rheumatology fellowship at UT Southwestern in Dallas.
Dr. Kavanaugh  was an inaugural member and has remained an active member of the Academy of Clinician Scholars. Since 2006, he has served as Divisional Representative to the UCSD Medical Group Quality Council, with responsibility for quality improvement within the division.

 

About the Lab

The Kavanaugh lab conducts clinical research in  the following:

  • Lupus (SLE)
  • Rheumatoid Arthritis (RA)
  • Ankylosing Spondylitis (AS)
  • Scleroderma (PSS)
  • Gout
  • Psoriatic arthritis

Support our work

Your gifts help us bridge the gap between discovery and patient care. To partner directly with us please contact:mdasilva@ucsd.edu

 

Research Highlights

  • Department of Defense
    PSTD/TBI Clinical Consortium-Coordinating Center. Admin Core Major Goals: Develop Clinical trials relevant to PTSD and TBI for the Clinical Consortium. 
  • 3 U01 NS058030-04S1Preclinical and Clinical Studies of Cobinamide, A New Cyanide  Detoxifying Agent    Major goals: Develop clinical studies of cobinamide.
  • P00000028802 (NS063718) Combined use of cobinamide and a 3-Mercaptopyruvate prodrug for cyanide poisoning. Major goals: Develop clinical studies of this regimen.
  • Sub P00000028801 (NS063718) Combined use of cobinamide and a 3-Mercaptopyruvate prodrug for cyanide poisoning. Major goals. Develop clinical studies of this regimen.
  • 1 U54 RR023504-01A1 San Diego Clinical and Translational Research Institute.Major goals:Enhance translational research across UCSD and the San Diego community.